Spectrum of benign breast disorders in a university hospital

Other OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study of 234 benign breast disorder cases found breast pain and modularity to be most common, with vitamin E and danazol showing efficacy for mastalgia at the cost of side effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In a period of 2 years, 234 cases of benign breast disorder were studied. Breast pain and modularity was the commonest group (70.1%) followed by fibroadenoma (17.5%). Cyclical mastalgia (61.5%) is more common than non-cyclical mastalgia (38.5%). The age of the patients with cyclical mastalgia was significantly lesser than patients with non-cyclical mastalgia. Cyclical mastalgia was seen only in premenopausal females while non-cyclical mastalgia was also seen in postmenopausal females. Treatment with vitamin E showed 41% response rate with minimal side-effects while treatment with danazol showed 72.1% response rate but was associated with side-effects in one third of the patients.

My notes (saved in your browser only)

MeSH descriptors

Breast Diseases Breast Diseases Adult Breast Diseases Danazol Danazol Danazol Estrogen Antagonists Estrogen Antagonists Estrogen Antagonists Female Humans India Menstrual Cycle Middle Aged Pain Pain Periodicity Vitamin E Vitamin E

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-10T11:09:49.572039+00:00
pubmed
last seen: 2026-10-08T22:00:22.376048+00:00
License: CC0 · commercial use OK